2025 Volume 53 Issue 5 Pages 327-332
Herein, we report two cases of delayed cerebral ischemia (DCI) associated with angiographic vasospasm (AVS) that occurred after the completion of clazosentan treatment: one newly developed and one progressive.
Case 1: A female in her 80s (World Federation of Neurosurgical Societies [WFNS] grade 2) underwent coil embolization for a right middle cerebral artery (MCA) bifurcation aneurysm. No AVS or DCI was observed during clazosentan administration (days 3–14). However, on days 17, 19, and 20, AVS/DCI developed in the right MCA, requiring intra-arterial fasudil hydrochloride injections. Dehydration was suspected to be a contributing factor.
Case 2: A female in her 50s (WFNS grade 5) underwent coil embolization for aneurysms in the anterior communicating artery (Acom) and the paraclinoid internal carotid artery. During clazosentan administration, AVS or DCI was observed in the MCA and Acom on day 10. AVS or DCI recurred on day 17 and was treated with intravenous fasudil hydrochloride and increased fluid supplementation.
These cases suggest that careful observation for DCI is required after the completion of clazosentan treatment.